Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quartz II/III: OBV/PTV/r + Sofosbuvir in HCV GT2/3
NCT02292719Phase 2Completed
- Sponsor
- AbbVie Inc.
- Start
- Dec 2014
- Primary completion
- Jul 2017
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of ombitasvir + paritaprevir + ritonavir in hepatitis C (HCV), sponsored by AbbVie Inc.. Started Dec 2014; status: completed.
02
Drugs
ombitasvir + paritaprevir + ritonavir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT02292719.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02292719.